Communications Medicine (Sep 2022)
Medication history-wide association studies for pharmacovigilance of pregnant patients
Abstract
Challa et al. used 2.8 million electronic health records for proactive pharmacovigilance program development, by rapidly generating and validating hypotheses between medication use during pregnancy and neonatal neurodevelopmental defects. They identify five drug classes for which deeper safety signal evaluation may improve product marketing.